BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16522576)

  • 21. New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund.
    Martin JF; Marshall J
    Vaccine; 2003 Jan; 21(7-8):587-92. PubMed ID: 12531322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines.
    Widdowson MA; Steele D; Vojdani J; Wecker J; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S1-8. PubMed ID: 19817589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving the health of the global poor.
    Jha P; Mills A; Hanson K; Kumaranayake L; Conteh L; Kurowski C; Nguyen SN; Cruz VO; Ranson K; Vaz LM; Yu S; Morton O; Sachs JD
    Science; 2002 Mar; 295(5562):2036-9. PubMed ID: 11896266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries.
    Levine OS; Cherian T; Shah R; Batson A
    J Health Popul Nutr; 2004 Sep; 22(3):268-74. PubMed ID: 15609779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protecting the world's children: the story of WHO's immunization programme.
    Bland J; Clements J
    World Health Forum; 1998; 19(2):162-73. PubMed ID: 9652217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
    Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P
    Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage.
    Lim SS; Stein DB; Charrow A; Murray CJ
    Lancet; 2008 Dec; 372(9655):2031-46. PubMed ID: 19070738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The introduction of new vaccines into developing countries. IV: Global Access Strategies.
    Mahoney RT; Krattiger A; Clemens JD; Curtiss R
    Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Economic aspects of health care in relation to vaccination programs].
    Kuszewski K
    Przegl Epidemiol; 2003; 57 Suppl 1():9-13. PubMed ID: 12920999
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
    Jeuland M; Whittington D
    Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introducing auto-disable syringes to the national immunization programme in Madagascar.
    Drain PK; Ralaivao JS; Rakotonandrasana A; Carnell MA
    Bull World Health Organ; 2003; 81(8):553-60. PubMed ID: 14576886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Out-of-pocket costs of childhood immunizations: a comparison by type of insurance plan.
    Molinari NA; Kolasa M; Messonnier ML; Schieber RA
    Pediatrics; 2007 Nov; 120(5):e1148-56. PubMed ID: 17974710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global vaccination meets global terror.
    CMAJ; 2002 Oct; 167(8):837, 839. PubMed ID: 12406926
    [No Abstract]   [Full Text] [Related]  

  • 37. Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011-20.
    Ozawa S; Clark S; Portnoy A; Grewal S; Brenzel L; Walker DG
    Health Aff (Millwood); 2016 Feb; 35(2):199-207. PubMed ID: 26858370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Estimated costs of the expanded program of immunization in the health district of Grand Bassam, Cote d'Ivoire].
    Douba A; Dagnan SN; Zengbe-Acray P; Aka J; Lépri-Aka N
    Sante Publique; 2011; 23(2):113-21. PubMed ID: 21896225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 May; 55(18):511-5. PubMed ID: 16691182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
    Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
    Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.